GlassScriptPhysician profile
Asif Jafferani
NPI 1417398843
$13,593.69
in general payments reported to CMS, 2019-2025
28 companies · $6,848 in 2025
The $6,848 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,448 · 2020: $14.41 · 2021: $775 · 2022: $1,304 · 2023: $751 · 2024: $454 · 2025: $6,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,301 · Food and Beverage: $3,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,301.36 |
| Food and Beverage | $3,751.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,395.24 | 2021-2025 | Evera Mri Xt Dr Surescan, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $3,211.72 | 2019-2025 | Watchman Flx, Accolade Sr |
| Biosense Webster, INC. | $1,836.57 | 2021-2025 | Carto 3, Qdot Micro |
| Medical Device Business Services, INC. | $1,024.60 | 2019 | |
| Atricure, INC. | $335.23 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbott Laboratories | $280.75 | 2021-2025 | Gallant, Jot Dx |
| Cvrx, INC. | $211.91 | 2025 | Barostim Neo System |
| Vital Connect, INC | $177.46 | 2023 | Vitalpatch Rtm |
| Impulse Dynamics (USA) INC. | $149.96 | 2021-2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $135.56 | 2023 | Assure Wcd |
| Chiesi USA, INC. | $131.54 | 2025 | Kengreal |
| Pfizer INC. | $105.19 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $97.29 | 2022-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $67.65 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $57.09 | 2024-2025 | Eliquis |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $52.42 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Intuitive Surgical, INC. | $48.73 | 2025 | |
| Alnylam Pharmaceuticals INC. | $44.06 | 2022-2025 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.95 | 2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $31.01 | 2023-2025 | |
| Inspire Medical Systems, INC. | $27.33 | 2023 | Inspire |
| Becton, Dickinson and Company | $25.05 | 2025 | Hemosphere |
| Teleflex LLC | $23.51 | 2025 | Langston |
| Edwards Lifesciences Corporation | $21.48 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals International, Plc | $19.95 | 2024 | Arcalyst |
| Amgen INC. | $15.39 | 2025 | Repatha |
| Medtronic Vascular, INC. | $14.41 | 2020 | |
| Cardiva Medical, INC. | $13.64 | 2025 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Jafferani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.